Login to myESAIC Membership


The ESAIC is dedicated to supporting professionals in anaesthesiology and intensive care by serving as the hub for development and dissemination of valuable educational, scientific, research, and networking resources.



The ESAIC hosts the Euroanaesthesia and Focus Meeting congresses that serve as platforms for cutting-edge science and innovation in the field. These events bring together experts, foster networking, and facilitate knowledge exchange in anaesthesiology, intensive care, pain management, and perioperative medicine. Euroanaesthesia is one of the world’s largest and most influential scientific congresses for anaesthesia professionals. Held annually throughout Europe, our congress is a contemporary event geared towards education, knowledge exchange and innovation in anaesthesia, intensive care, pain and perioperative medicine, as well as a platform for immense international visibility for scientific research.


Professional Growth

The ESAIC's mission is to foster and provide exceptional training and educational opportunities. The ESAIC ensures the provision of robust and standardised examination and certification systems to support the professional development of anaesthesiologists and to ensure outstanding future doctors in the field of anaesthesiology and intensive care.



The ESAIC aims to advance patient outcomes and contribute to the progress of anaesthesiology and intensive care evidence-based practice through research. The ESAIC Clinical Trial Network (CTN), the Academic Contract Research Organisation (A-CRO), the Research Groups and Grants all contribute to the knowledge and clinical advances in the peri-operative setting.

Learn more about the ESAIC Clinical Trial Network (CTN) and the associated studies.


EU Projects

The ESAIC is actively involved as a consortium member in numerous EU funded projects. Together with healthcare leaders and practitioners, the ESAIC's involvement as an EU project partner is another way that it is improving patient outcomes and ensuring the best care for every patient.


Patient Safety

The ESAIC aims to promote the professional role of anaesthesiologists and intensive care physicians and enhance perioperative patient outcomes by focusing on quality of care and patient safety strategies. The Society is committed to implementing the Helsinki Declaration and leading patient safety projects.



To ESAIC is committed to implementing the Glasgow Declaration and drive initiatives towards greater environmental sustainability across anaesthesiology and intensive care in Europe.



The ESAIC works in collaboration with industry, national societies, and specialist societies to promote advancements in anaesthesia and intensive care. The Industry Partnership offers visibility and engagement opportunities for industry participants with ESAIC members, facilitating understanding of specific needs in anaesthesiology and in intensive care. This partnership provides resources for education and avenues for collaborative projects enhancing science, education, and patient safety. The Specialist Societies contribute to high-quality educational opportunities for European anaesthesiologists and intensivists, fostering discussion and sharing, while the National Societies, through NASC, maintain standards, promote events and courses, and facilitate connections. All partnerships collectively drive dialogue, learning, and growth in the anaesthesiology and intensive care sector.



Guidelines play a crucial role in delivering evidence-based recommendations to healthcare professionals. Within the fields of anaesthesia and intensive care, guidelines are instrumental in standardizing clinical practices and enhancing patient outcomes. For many years, the ESAIC has served as a pivotal platform for facilitating continuous advancements, improving care standards and harmonising clinical management practices across Europe.



With over 40 years of publication history, the EJA (European Journal of Anaesthesiology) has established itself as a highly respected and influential journal in its field. It covers a wide range of topics related to anaesthesiology and intensive care medicine, including perioperative medicine, pain management, critical care, resuscitation, and patient safety.



Becoming a member of ESAIC implies becoming a part of a vibrant community of nearly 8,000 professionals who exchange best practices and stay updated on the latest developments in anaesthesiology, intensive care and perioperative medicine. ESAIC membership equips you with the tools and resources necessary to enhance your daily professional routine, nurture your career growth, and play an active role in advancing anaesthesiology, intensive care and perioperative medicine.

Membership opportunities
at the ESAIC

Congress Newsletter 2022

Live Report - Best Abstract Competition 2022

The 2022 Euroanaesthesia Best Abstract competition saw a very high standard of research, with all six presentations impressing the judging panel of Barak Cohen (Tel Aviv-Yafo, Israel, chair), Daniela Ionescu (Cluj Napoca, Romania), and Isabell Pekrul (Munich, Germany) then selected our three winners.

All the finalists’ abstracts can be read by clicking here

The first prize of 3,000 Euros was awarded to Dr Ana Arnalich Montiel, who works as a Consultant at the Department of Anesthesia and Intensive Care Medicine of Gregorio Marañón University Hospital in Madrid for her study ‘Maintenance over time of the effect produced by esmolol on the structure of coronary arteries’.

The second prize of 2,000 Euros went to Vittoria Arslan-Carlon (New York at Memorial Sloan Kettering Cancer Center) for her study Pain with movement after hepatic resection: a randomized trial of epidural patient controlled analgesia versus intravenous patient controlled analgesia’; and the third prize of 1,000 Euros was awarded to Dr Åsa Östlund (Karolinska University Hospital in Stockholm, Sweden) for her study prospective study on complications of paediatric midline catheters‘.

The other finalists were Dr Maksym Barsa of Danylo Halytsky Lviv National Medical University, Ukraine; Dr Rokus van den Dool, Amsterdam UMC, Netherlands; and Dr Raquel Okoshi, Hospital de Clínicas de São Bernardo do Campo, Sao Paulo, Brazil.

Here our winner Dr Ana Arnalich Montiel tells us a little about her and her study. She has specialised in Critical Care at Saint George’s Hospital in London, where she completed her PhD. In addition to her work at Gregorio Marañón University Hospital in Madrid, she works as an associate professor at the Medical School of Complutense University in Madrid. She is an examiner of the European Diploma in Anaesthesiology and Intensive Care, and also belongs to the study group “Regenerative Medicine and Cardiovascular System development” at Gregorio Marañon Research Institute.

Q: Congratulations on first prize Ana! How are you feeling?

A: Thank you very much! I really enjoyed the session and I want to congratulate all the other finalists too on their great presentations. I am so happy – but now I must quickly go and catch my plane back to Spain!

Q: Before you go, please could you tell us a little a bit about why you did this study?

A: Vascular remodelling leads to an increase in cardiovascular events and mortality. Consequently, finding a therapy to reverse this situation is highly desirable for our patients. We have previously demonstrated that esmolol produces early regression in vascular remodelling in spontaneously hypertensive rats (SHRs). This was the first time that a drug showed a beneficial effect on coronary artery damage, after a very short interval (48 hours) of therapy. Therefore, we decided to conduct this study to investigate whether vascular remodelling is maintained over time after treatment withdrawal.

Q: And lastly, please tell us about the future implications of the work. 

A: In our study, we have demonstrated that the beneficial effect of esmolol on vascular remodelling is maintained over time after treatment is withdrawn. If these findings were demonstrated in humans, esmolol would be the desirable choice to treat hypertension in patients with associated coronary disease, in order to decrease their cardiovascular risk.

Thanks Ana, congratulations and buen viaje!

Winner Dr Ana Arnalich Montiel celebrates with colleagues

Left to right: Our three panel judges with winner Ana Arnalich Montiel, 3rd place Dr Åsa Östlund and 2nd place Vittoria Arslan-Carlon

All six Best Abstract Finalists (standing) with our panel of judges (sitting)

Read More of our special newsletter covering our congress.